Holen Sie sich die Stockscreener-App
0.7247
0.61%
0.0044
Geovax Labs Inc Aktie (GOVX) Neueste Nachrichten
How does GeoVax Labs Inc. generate profit in a changing economyAchieve rapid portfolio growth with smart picks - jammulinksnews.com
What institutional investors are buying GeoVax Labs Inc. Equity Warrant stockBuild a diversified portfolio for risk management - jammulinksnews.com
Is GeoVax Labs Inc. a growth stock or a value stockBuild wealth faster with disciplined trading - jammulinksnews.com
What analysts say about GeoVax Labs Inc. stockHigh-velocity gains - jammulinksnews.com
Is GeoVax Labs Inc. a good long term investmentExplosive capital appreciation - jammulinksnews.com
What drives GeoVax Labs Inc. Equity Warrant stock priceBuild wealth steadily with smart stock selection - jammulinksnews.com
What are the technical indicators suggesting about GeoVax Labs Inc.Build wealth faster with disciplined trading - jammulinksnews.com
What institutional investors are buying GeoVax Labs Inc. stockOutstanding yields - jammulinksnews.com
What is the risk reward ratio of investing in GeoVax Labs Inc. Equity Warrant stockExponentially increasing returns - jammulinksnews.com
Why is GeoVax Labs Inc. Equity Warrant stock attracting strong analyst attentionAchieve rapid returns with smart investment plans - jammulinksnews.com
Is GeoVax Labs Inc. Equity Warrant stock overvalued or undervaluedGet alerts on top growth stocks daily - jammulinksnews.com
When is GeoVax Labs Inc. Equity Warrant stock expected to show significant growthPowerful market insights - jammulinksnews.com
How strong is GeoVax Labs Inc. Equity Warrant company’s balance sheetExplosive portfolio gains - jammulinksnews.com
Published on: 2025-08-03 04:54:01 - jammulinksnews.com
What catalysts could drive GeoVax Labs Inc. Equity Warrant stock higher in 2025 - jammulinksnews.com
What are analysts’ price targets for GeoVax Labs Inc. Equity Warrant in the next 12 monthsFree Trading Strategy Suggestions - jammulinksnews.com
Is GeoVax Labs Inc. stock poised for growthBuy Signal Based on Chart Analysis Confirmed - metal.it
GeoVax Labs Faces Nasdaq Deficiency Over Stock Price - AInvest
GeoVax Labs receives Nasdaq notice for non-compliance with minimum bid price - Investing.com Australia
Is it the right time to buy GeoVax Labs Inc. stockBest Dividend Outlook For Consistent Profits - jammulinksnews.com
Published on: 2025-08-01 19:06:07 - metal.it
How does GeoVax Labs Inc. Equity Warrant generate profit in a changing economyAdvanced Screener Entry Points For Consistent Profits - jammulinksnews.com
Smyrna biotech company chases European approvals amid cash crunchAtlanta Business Chronicle - The Business Journals
How volatile is GeoVax Labs Inc. stock compared to the marketFree Stock Trend Scanner That Work - jammulinksnews.com
GeoVax Labs Inc. Equity Warrant Company Revenue and Profit Trends: A Deep DiveBuy Low Sell High Stock Watch Strategy in Focus - metal.it
Securing the Future: Strategic Investments in U.S. Biodefense and GeoVax's MVA Vaccine Platform - AInvest
GeoVax Urges Immediate Action on Pandemic Preparedness as Biodefense Gaps Expose Fragile Supply Chains - Yahoo Finance
MACD Signals Flash Warning for GeoVax Labs Inc. StockCommunity Strategy With High Win Rate Backtested - beatles.ru
Published on: 2025-07-29 20:26:14 - metal.it
GeoVax Labs Revenue Doubles in Q2 - AOL.com
GeoVax Accelerates Development of GEO-MVA Vaccine Amid Expanding Global Mpox Crisis and Reaffirmed WHO Emergency Designation - NewMediaWire
GOVX: Geovax Labs Maintains "Buy" Rating and $9 Price Target | G - GuruFocus
GeoVax Accelerates Development of GEO-MVA Vaccine Amid Expanding Global Mpox Crisis and Reaffirmed WHO Emergency Designation | Dow Theory Letters - FinancialContent
What caused GOVX's Q2 2024 profit turnaround? - AInvest
What are the latest earnings results for GeoVax Labs Inc.Low Risk Alerts Backed By Experts - jammulinksnews.com
Geovax Labs shares rise 4.73% premarket after Q2 2025 earnings call. - AInvest
GeoVax Labs 2025 Q2 Earnings Misses Targets as Net Loss Widens - AInvest
GeoVax Labs Q2 2025 Earnings Call Transcript - MarketBeat
Geovax Labs Inc (GOVX) Q2 2025 Earnings Call Highlights: Revenue Surge and Strategic ... - Yahoo Finance
GeoVax Advances in Vaccine and Immunotherapy Development with Promising Clinical Data - citybuzz -
GeoVax Labs Inc. Breaks Losing Streak — Is the Trend ReversingOptimized Watchlist With Daily Adjustments Launched - metal.it
GeoVax's 2025 Q2: Unpacking Contradictions in Vaccine Manufacturing and Clinical Trials - AInvest
GeoVax Labs Q2 2025 Earnings Conference Call Transcript - AInvest
Earnings call transcript: GeoVax Labs Q2 2025 sees revenue surge, stock dips - Investing.com Nigeria
GeoVax Reports Second Quarter 2025 Financial Results and Provides Business Update - Yahoo Finance
Published on: 2025-07-28 20:40:12 - metal.it
GeoVax Advances Needle-Free Vaccine Technology with HD-MAP Platform Study - citybuzz -
GeoVax Announces Research Program to Evaluate Needle-Free, Self-Administered GEO-MVA Vaccine Using Vaxxas Microarray Patch Technology - Yahoo Finance
0.93%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):